Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method.

MLA

Lin, Yu, et al. “Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method.” ACS Omega, vol. 7, no. 6, July 2022, pp. 22850–60. EBSCOhost, https://doi.org/10.1021/acsomega.2c02600.

APA

Lin, Y., Zhu, J., Zhang, J., Dai, J., Liu, S., Arroyo, A., Rose, M., Singal, A. G., Parikh, N. D., & Lubman, D. M. (2022). Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method. ACS Omega, 7(6), 22850–22860. https://doi.org/10.1021/acsomega.2c02600

Chicago

Lin, Yu, Jianhui Zhu, Jie Zhang, Jianliang Dai, Suyu Liu, Ana Arroyo, Marissa Rose, Amit G. Singal, Neehar D. Parikh, and David M. Lubman. 2022. “Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method.” ACS Omega 7 (6): 22850–60. doi:10.1021/acsomega.2c02600.